Search research articles
Contact Us
Filters
Showing results (111-120 of 175) with videos related to
Page
of 18
Sort By:
HGG Advances
|
January 9, 2026
Recessive AARS1 variants perturb human and mouse development
Jennifer L Watts, Nicole Costantino, Ammar Husami, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 5, 2026
Shortened Cortical Silent Period in Children with Attention Deficit Hyperactivity Disorder
Darius S Feier, Donald L Gilbert, Deana Crocetti, et al.
Pediatric Neurology
|
June 22, 2026
Multiecho Resting-State Functional Magnetic Resonance Imaging Analysis of Attention-Deficit/Hyperactivity Disorder Severity and Motor Dysfunction in a Pediatric Sample of Neurofibromatosis Type 1
Mitchell A Batschelett, Karlee Y Migneault, Lindsey Aschbacher-Smith, et al.
Journal of Child and Adolescent Psychopharmacology
|
March 24, 2016
Abnormal Cortical Plasticity in Youth with Autism Spectrum Disorder: A Transcranial Magnetic Stimulation Case-Control Pilot Study
Ernest V Pedapati, Donald L Gilbert, Craig A Erickson, et al.
Journal of Child and Adolescent Psychopharmacology
|
April 24, 2025
Determining Clinically Meaningful Improvement in Children and Adolescents with Tourette Syndrome Receiving Pharmacotherapy
Joseph F McGuire, George B Karkanias, Richard M Bittman, et al.
Movement Disorders Clinical Practice
|
May 12, 2025
Safety and Effect of 12-Month Ecopipam Treatment in Pediatric Patients with Tourette Syndrome
Donald L Gilbert, David J B Kim, Meredith M Miller, et al.
Neurology
|
July 19, 2019
Motor cortex inhibition and modulation in children with ADHD
Donald L Gilbert, David A Huddleston, Steve W Wu, et al.
Brain : a Journal of Neurology
|
June 9, 2006
Dopamine transporter genotype influences the physiological response to medication in ADHD
Donald L Gilbert, Zhewu Wang, Floyd R Sallee, et al.
Therapeutic Advances in Neurological Disorders
|
March 2, 2026
Plain Language Summary of a Phase 2b Randomized Controlled Trial of Ecopipam and Its 12-Month Open-Label Extension in Children and Adolescents With Tourette Syndrome
Donald L Gilbert, David J B Kim, Meredith M Miller, et al.
Journal of Child Neurology
|
January 14, 2014
Reduced short interval cortical inhibition correlates with atomoxetine response in children with attention-deficit hyperactivity disorder (ADHD)
Tina H Chen, Steve W Wu, Jeffrey A Welge, et al.
Page
of 18
Search research articles
Search
Showing results (111-120 of 175) with videos related to
Sort By:
Page
of 18
HGG Advances
|
January 9, 2026
Recessive AARS1 variants perturb human and mouse development
Jennifer L Watts, Nicole Costantino, Ammar Husami, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 5, 2026
Shortened Cortical Silent Period in Children with Attention Deficit Hyperactivity Disorder
Darius S Feier, Donald L Gilbert, Deana Crocetti, et al.
Pediatric Neurology
|
June 22, 2026
Multiecho Resting-State Functional Magnetic Resonance Imaging Analysis of Attention-Deficit/Hyperactivity Disorder Severity and Motor Dysfunction in a Pediatric Sample of Neurofibromatosis Type 1
Mitchell A Batschelett, Karlee Y Migneault, Lindsey Aschbacher-Smith, et al.
Journal of Child and Adolescent Psychopharmacology
|
March 24, 2016
Abnormal Cortical Plasticity in Youth with Autism Spectrum Disorder: A Transcranial Magnetic Stimulation Case-Control Pilot Study
Ernest V Pedapati, Donald L Gilbert, Craig A Erickson, et al.
Journal of Child and Adolescent Psychopharmacology
|
April 24, 2025
Determining Clinically Meaningful Improvement in Children and Adolescents with Tourette Syndrome Receiving Pharmacotherapy
Joseph F McGuire, George B Karkanias, Richard M Bittman, et al.
Movement Disorders Clinical Practice
|
May 12, 2025
Safety and Effect of 12-Month Ecopipam Treatment in Pediatric Patients with Tourette Syndrome
Donald L Gilbert, David J B Kim, Meredith M Miller, et al.
Neurology
|
July 19, 2019
Motor cortex inhibition and modulation in children with ADHD
Donald L Gilbert, David A Huddleston, Steve W Wu, et al.
Brain : a Journal of Neurology
|
June 9, 2006
Dopamine transporter genotype influences the physiological response to medication in ADHD
Donald L Gilbert, Zhewu Wang, Floyd R Sallee, et al.
Therapeutic Advances in Neurological Disorders
|
March 2, 2026
Plain Language Summary of a Phase 2b Randomized Controlled Trial of Ecopipam and Its 12-Month Open-Label Extension in Children and Adolescents With Tourette Syndrome
Donald L Gilbert, David J B Kim, Meredith M Miller, et al.
Journal of Child Neurology
|
January 14, 2014
Reduced short interval cortical inhibition correlates with atomoxetine response in children with attention-deficit hyperactivity disorder (ADHD)
Tina H Chen, Steve W Wu, Jeffrey A Welge, et al.
Page
of 18